First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling As a Driver Event in Hepatocellular Carcinoma
Richard D. Kim,Debashis Sarker,Tim Meyer,Thomas Yau,Teresa Macarulla,Joong-Won Park,Su Pin Choo,Antoine Hollebecque,Max W. Sung,Ho-Yeong Lim,Vincenzo Mazzaferro,Joerg Trojan,Andrew X. Zhu,Jung-Hwan Yoon,Sunil Sharma,Zhong-Zhe Lin,Stephen L. Chan,Sandrine Faivre,Lynn G. Feun,Chia-Jui Yen,Jean-Francois Dufour,Daniel H. Palmer,Josep M. Llovet,Melissa Manoogian,Meera Tugnait,Nicolas Stransky,Margit Hagel,Nancy E. Kohl,Christoph Lengauer,Cori Ann Sherwin,Oleg Schmidt-Kittler,Klaus P. Hoeflich,Hongliang Shi,Beni B. Wolf,Yoon-Koo Kang pubmed（2023）
关键词
Fibroblast Growth Factor
AI 理解论文
溯源树
样例
